Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Colistin Monotherapy Versus Colistin Combined With Fosfomycin Against Carbapenem-Resistant Acinetobacter Baumannii Infections

NCT06570850 is registered in ClinicalTrials.gov with Chiang Mai University as lead sponsor.

NCT NCT06570850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06570850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Colistin Monotherapy Versus Colistin Combined With Fosfomycin Against Carbapenem-Resistant Acinetobacter Baumannii Infections
Lead sponsor
Chiang Mai University
Phase
Phase 4
Overall status
Recruiting
Start date
April 1, 2023
Completion date
July 31, 2025
Enrollment
188 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infection due to carbapenem resistant acinetobacter